Coronavirus outbreak

As the coronavirus pandemic endures, the socio-economic implications of race and gender in contracting Covid-19 and dying from it have been laid bare. Artificial intelligence (AI) is playing a key role in the response, but it could also be exacerbating inequalities within our health systems – a critical concern that is dragging the technology’s limitations back into the spotlight.

The development of new medical technologies based on cutting-edge discoveries has accelerated during the coronavirus pandemic and is helping us respond to the health crisis. But for these technologies to flourish, attitudes and scepticism among investors still need to change, say researchers and start-ups.

On the southern outskirts of the city of Owensboro in Kentucky, US, there is a square, nondescript building. Inside, rows and rows of small plants are growing under artificial lights. This is a new generation biotech venture: a molecular farm. Others are springing up across the US and elsewhere – and they farm vaccines. This means that if we find a coronavirus vaccine that works, their produce could be used by households worldwide.

The pandemic has caused disruption around the world, but it could also be an opportunity to make some much needed social and environmental changes as countries try to adapt and recover from the crisis.

More than six months into the coronavirus crisis, data show that not just age, but also biological sex plays a pivotal role in the manifestation and response to Covid-19, with more men dying from acute infections versus women in the short term. This discrepancy has shined a spotlight on a key theme that has gained traction in recent years: is enough being done to account for sex and gender in disease and medicine? Not enough, says Dr Sabine Oertelt-Prigione, the chair of sex and gender-sensitive medicine at Radboud University in the Netherlands and a member of the European Commission’s expert group on gendered innovations.

From bioluminescent testing kits to disinfecting robots, Horizon examines six innovations and technologies currently being developed to tackle the coronavirus.

We’re only at the start of the coronavirus pandemic although the second wave may take a different form to the first one, says veteran virologist Professor Peter Piot, who has spent the past 40 years tracking down and fighting viruses.

To begin with, it was just anecdotal reports. Ear, nose and throat specialists from around the world were sharing their experiences on online message boards – they were all seeing a spike in patients experiencing anosmia, a loss of smell.

Some people’s immune systems contain pre-existing protection against coronavirus, indicating that they have encountered a similar infection to Covid-19 before, according to Dr Aleksandra Walczak, a physicist at École Normale Supérieure in Paris, France.

We are seeing a failure of global health governance in response to Covid-19 because there are too many agencies with different interests, according Professor Colin McInnes, pro-vice chancellor at Aberystwyth University in Wales, UK, who says global institutions such as the World Health Organization and World Bank should stand together in crises.